Tayo Adekiya to Humans
This is a "connection" page, showing publications Tayo Adekiya has written about Humans.
Connection Strength
0.268
-
Adekiya TA, Hudson T, Bakare O, Ameyaw EE, Adebayo A, Olajubutu O, Adesina SK. PSMA-targeted combination brusatol and docetaxel nanotherapeutics for the treatment of prostate cancer. Biomed Pharmacother. 2024 Aug; 177:117125.
Score: 0.046
-
Adekiya TA, Owoseni O. Emerging frontiers in nanomedicine targeted therapy for prostate cancer. Cancer Treat Res Commun. 2023; 37:100778.
Score: 0.044
-
Omoboyede V, Onile OS, Oyeyemi BF, Aruleba RT, Fadahunsi AI, Oke GA, Onile TA, Ibrahim O, Adekiya TA. Unravelling the anti-inflammatory mechanism of Allium cepa: an integration of network pharmacology and molecular docking approaches. Mol Divers. 2024 Apr; 28(2):727-747.
Score: 0.042
-
Adekiya TA, Kumar P, Kondiah PPD, Pillay V, Choonara YE. Synthesis and therapeutic delivery approaches for praziquantel: a patent review (2010-present). Expert Opin Ther Pat. 2021 Sep; 31(9):851-865.
Score: 0.037
-
Adekiya TA, Aruleba RT, Klein A, Fadaka AO. In silico inhibition of SGTP4 as a therapeutic target for the treatment of schistosomiasis. J Biomol Struct Dyn. 2022 05; 40(8):3697-3705.
Score: 0.036
-
Adekiya TA, Aruleba RT, Oyinloye BE, Okosun KO, Kappo AP. The Effect of Climate Change and the Snail-Schistosome Cycle in Transmission and Bio-Control of Schistosomiasis in Sub-Saharan Africa. Int J Environ Res Public Health. 2019 12 26; 17(1).
Score: 0.033
-
Ojo OA, Aruleba RT, Adekiya TA, Sibuyi NRS, Ojo AB, Ajiboye BO, Oyinloye BE, Adeola HA, Fadaka AO. Deciphering the interaction of puerarin with cancer macromolecules: An in silico investigation. J Biomol Struct Dyn. 2022 02; 40(2):848-859.
Score: 0.009
-
Ojo OA, Afon AA, Ojo AB, Ajiboye BO, Okesola MA, Aruleba RT, Adekiya TA, Oyinloye BE. Spondias mombim L. (Anacardiaceae): Chemical fingerprints, inhibitory activities, and molecular docking on key enzymes relevant to erectile dysfunction and Alzheimer's diseases. J Food Biochem. 2019 03; 43(3):e12772.
Score: 0.008
-
Aruleba RT, Adekiya TA, Oyinloye BE, Masamba P, Mbatha LS, Pretorius A, Kappo AP. PZQ Therapy: How Close are we in the Development of Effective Alternative Anti-schistosomal Drugs? Infect Disord Drug Targets. 2019; 19(4):337-349.
Score: 0.008
-
Aruleba RT, Adekiya TA, Oyinloye BE, Kappo AP. Structural Studies of Predicted Ligand Binding Sites and Molecular Docking Analysis of Slc2a4 as a Therapeutic Target for the Treatment of Cancer. Int J Mol Sci. 2018 Jan 28; 19(2).
Score: 0.007